• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Edge Higher; Amazon And iRobot Agree To Terminate Acquisition Deal

    1/29/24 9:48:40 AM ET
    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Catalog/Specialty Distribution
    Consumer Discretionary
    Auto Manufacturing
    Consumer Discretionary
    Get the next $AMZN alert in real time by email

    U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining around 25 points on Monday.

    Following the market opening Monday, The Dow traded up 0.07% to 38,134.80 while the NASDAQ rose 0.04% to 15,461.42. The S&P 500 also fell, dropping, 0.04% to 4,893.17.

    Check This Out: American Airlines To Rally Around 32%? Here Are 10 Top Analyst Forecasts For Monday

     

    Leading and Lagging Sectors

     

    Consumer discretionary shares rose by 0.2% on Monday.

    In trading on Monday, communication services shares fell by 0.3%.

     

    Top Headline

     

    Amazon.Com Inc (NASDAQ:AMZN) and iRobot Corp (NASDAQ:IRBT) mutually agreed to terminate their $1.7 billion merger deal.

    This deal would have allowed Amazon to invest in continued innovation by iRobot and support iRobot in lowering prices on product customers.

     

    Equities Trading UP

     

    Palisade Bio, Inc. (NASDAQ:PALI) shares shot up 132% to $1.23 after the company requested the withdrawal of a recently filed registration statement. Also, the company announced preclinical data of its lead program PALI-2108 at the 2024 Crohn's & Colitis Congress.

    Shares of OneMedNet Corporation (NASDAQ:ONMD) got a boost, surging 91% to $1.0210. OneMedNet announced participation as an exhibitor at the 15ᵗʰ Annual SCOPE Summit.

    Revelation Biosciences, Inc. (NASDAQ:REVB) shares were also up, gaining 89% to $18.64.

     

    Equities Trading DOWN

     

    Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares dropped 67% to $1.43 after the company announced pricing of a roughly $9 million public offering.

    Shares of Arrival (NASDAQ:ARVL) were down 24% to $0.56.

    SMX (Security Matters) Public Limited Company (NYSE:SMX) was down, falling 21% to $0.3396 after gaining around 83% on Friday.

    Also Check This Out: Top 3 Consumer Stocks That May Crash In January

     

    Commodities

     

    In commodity news, oil traded down 1.2% to $77.06 while gold traded up 0.6% at $2,030.10.

    Silver traded down 0.7% to $23.03 on Monday while copper rose 0.1% to $3.8555.

     

    Euro zone

     

    European shares were mixed today. The eurozone’s STOXX 600 rose 0.1%, London’s FTSE 100 rose 0.1% while Spain’s IBEX 35 Index fell 0.6% The German DAX fell 0.4% French CAC 40 slipped 0.1% while Italy’s FTSE MIB Index fell 0.7%.

    The Credit Union Consumer Sentiment Index in Ireland climbed to 74.2 in January versus a reading of 62.4 in December.

     

    Asia Pacific Markets

     

    Asian markets closed mostly higher on Monday, with Japan’s Nikkei 225 gaining 0.77%, Hong Kong’s Hang Seng Index gaining 0.78% and China’s Shanghai Composite Index falling 0.92%. India’s S&P BSE Sensex, meanwhile, jumped 1.74%.

    Profits earned by Chinese industrial firms declined 2.3% year-over-year to CNY 7,685.83 billion last year. The Domestic Supply Price Index in Singapore declined 1.1% year-over-year in December, while Malaysia’s producer prices fell 1.3% year-over-year in December.

     

    Economics

     

    The Dallas Fed Manufacturing index will be released at 10:00 a.m. ET.

    Now Read This: Meta Platforms, Caterpillar And 2 Other Stocks Insiders Are Selling

     

    Get the next $AMZN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMZN
    $ARVL
    $IRBT
    $ONMD

    CompanyDatePrice TargetRatingAnalyst
    Amazon.com Inc.
    $AMZN
    4/20/2026$285.00 → $325.00Overweight
    KeyBanc Capital Markets
    Amazon.com Inc.
    $AMZN
    4/17/2026$280.00 → $285.00Buy
    Truist
    Palisade Bio Inc.
    $PALI
    4/9/2026$7.00Outperform
    Wolfe Research
    Amazon.com Inc.
    $AMZN
    4/7/2026$283.00 → $288.00Buy
    MoffettNathanson
    Palisade Bio Inc.
    $PALI
    3/26/2026$7.00Buy
    H.C. Wainwright
    Amazon.com Inc.
    $AMZN
    3/25/2026$265.00 → $280.00Overweight
    Analyst
    Palisade Bio Inc.
    $PALI
    2/25/2026$5.00Buy
    Stifel
    Amazon.com Inc.
    $AMZN
    2/23/2026$305.00 → $304.00Overweight
    Wells Fargo
    More analyst ratings

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    November 14, 2023 - FDA Roundup: November 14, 2023

    For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

    11/14/23 3:26:18 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    February 18, 2022 - FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States

    For Immediate Release: February 18, 2022 Today, the U.S. Food and Drug Administration is alerting the public that several categories of FDA-regulated products purchased from Jan. 1, 2021, through the present from Family Dollar stores in Alabama, Arkansas, Louisiana, Mississippi, Missouri and Tennessee may be unsafe for consumers to use. The impacted products originated from the company’s distribution facility in

    2/18/22 8:06:10 PM ET
    $ARVL
    Auto Manufacturing
    Consumer Discretionary

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KeyBanc Capital Markets reiterated coverage on Amazon with a new price target

    KeyBanc Capital Markets reiterated coverage of Amazon with a rating of Overweight and set a new price target of $325.00 from $285.00 previously

    4/20/26 9:30:36 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Truist reiterated coverage on Amazon with a new price target

    Truist reiterated coverage of Amazon with a rating of Buy and set a new price target of $285.00 from $280.00 previously

    4/17/26 8:45:07 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Wolfe Research initiated coverage on Palisade Bio with a new price target

    Wolfe Research initiated coverage of Palisade Bio with a rating of Outperform and set a new price target of $7.00

    4/9/26 8:43:44 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    SEC Filings

    View All

    OneMedNet Corp filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - OneMedNet Corp (0001849380) (Filer)

    4/20/26 5:15:33 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form PRE 14A filed by Palisade Bio Inc.

    PRE 14A - PALISADE BIO, INC. (0001357459) (Filer)

    4/17/26 4:30:34 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form S-8 filed by Revelation Biosciences Inc.

    S-8 - REVELATION BIOSCIENCES, INC. (0001810560) (Filer)

    4/15/26 4:13:19 PM ET
    $REVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Williams Donald Allen bought $8,356 worth of shares (5,000 units at $1.67), increasing direct ownership by 87% to 10,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/21/26 4:05:24 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Williams Donald Allen bought $9,400 worth of shares (5,000 units at $1.88), increasing direct ownership by 687% to 5,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/13/26 9:43:07 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Medical Officer Yu Jeffrey converted options into 2,307,549 shares, bought $959,586 worth of shares (2,010,479 units at $0.48) and was granted 245,000 shares, increasing direct ownership by 165% to 7,326,223 units (SEC Form 4)

    4 - OneMedNet Corp (0001849380) (Issuer)

    11/26/25 9:56:08 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    OneMedNet Goes Live with 80 Million Patient Journeys and Billions of Records

    MINNEAPOLIS, April 22, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-Driven Real-World Data (RWD), today announced that its OneMedNet iRWD™ Platform, built on Palantir Foundry, is now live and fully operational. This major commercialization milestone delivers searchable access to billions of records across 80 million patient journeys in seconds, transforming how life sciences organizations access and analyze multi-modal clinical data at unprecedented scale and speed. Key Commercial Milestones of iRWD™ Platform: OneMedNet iRWD™ Platform Now Live on Palantir Foundry~70%

    4/22/26 9:00:00 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    The AI Power Surge: Why Energy Infrastructure Is Becoming the Next Critical Bottleneck

    AUSTIN, Texas, April 21, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: Artificial intelligence (AI) is no longer just a software revolution; it is rapidly becoming an energy story. As AI models grow larger and more complex, the computational power required to train and operate them is driving a surge in electricity demand that is beginning to outpace existing infrastructure. Hyperscale data centers, once viewed as digital backbones, are now emerging as some of the most energy-intensive assets in the global economy. This shift is forcing governments, utilities and private industry to confront a new reality: energy infrastructure, not computing capability, may become the defining c

    4/21/26 8:30:00 AM ET
    $AMZN
    $CEG
    $MSFT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Electric Utilities: Central
    Utilities

    Quickplay's Triple Play of New Customers, Products and Partnerships Set to Dominate NAB 2026

    LAS VEGAS, April 19, 2026 /PRNewswire/ -- (2026 NAB Show) - Quickplay, the Content to Value Operating System, today unveiled a broad array of company news including: an AI-enriched solution that identifies social signals and trending topics, and connects them to relevant content within minutes; transformative customer deployments; and powerful industry research and partnerships. Debuting at NAB, Social Signals is a new technology within Quickplay AI Studio that identifies trending cultural moments and matches them with high-value content assets to automatically generate social-r

    4/19/26 10:20:00 AM ET
    $AMZN
    $GOOGL
    $GTN
    Catalog/Specialty Distribution
    Consumer Discretionary
    Computer Software: Programming Data Processing
    Technology

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Jassy Andrew R

    4 - AMAZON COM INC (0001018724) (Issuer)

    4/21/26 4:51:10 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 4 filed by Herrington Douglas J

    4 - AMAZON COM INC (0001018724) (Issuer)

    4/16/26 6:12:32 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 4 filed by Garman Matthew S

    4 - AMAZON COM INC (0001018724) (Issuer)

    4/9/26 5:02:33 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Leadership Updates

    Live Leadership Updates

    View All

    Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board

    Appointment strengthens Phase 2 development strategy for PALI-2108 in ulcerative colitis and fibrostenotic Crohn's disease; Phase 2 ulcerative colitis IND submission planned for first half of 2026 Carlsbad, CA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company advancing next-generation, once-daily oral PDE4 inhibitor prodrugs engineered for targeted delivery to the terminal ileum and colon, today announced the appointment of Bram Verstockt, MD, PhD, to its Clinical Advisory Board (CAB). Dr. Verstockt is an internationally recognized expert in inflammatory bowel disease (IBD) and a leader in precisi

    2/17/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Circana Appoints Highly Regarded Business Leaders to Board of Directors

    Chicago, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Circana LLC, a leading global provider of data, insights, and advisory services, today announced the appointment of three new members to its Board of Directors: Brian Cornell, Executive Chair of Target Corp.; Lauren Cooks Levitan, Co-Founder and Co-CEO of ROOT and Lead Independent Director at e.l.f. Beauty, Inc.; and Rohit Prasad, former Senior Vice President and Head Scientist of Artificial General Intelligence at Amazon.com, Inc. "These appointments strengthen the Board's ability to guide Circana's strategy and accelerate the value we deliver to our global clients," said Stuart Aitken, President and CEO of Circana. "We are focused on advancing

    2/11/26 8:00:00 AM ET
    $AMZN
    $TGT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Department/Specialty Retail Stores

    Palisade Bio Appoints Leading Global IBD Experts, Laurent Peyrin-Biroulet, MD, PhD and David T. Rubin, MD, to Its Clinical Advisory Board

    Internationally recognized leaders in inflammatory bowel disease bring deep expertise spanning ulcerative colitis, Crohn's disease, and late-stage clinical trial design Appointments strengthen Palisade Bio's clinical strategy as PALI-2108 advances toward Phase 2 development in ulcerative colitis and fibrostenotic Crohn's disease, with a Phase 2 UC IND submission planned for the first half of 2026 Carlsbad, CA, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today an

    1/29/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Financials

    Live finance-specific insights

    View All

    Amazon.com to Webcast First Quarter 2026 Financial Results Conference Call

    Amazon.com, Inc. (NASDAQ:AMZN) announced today that it will hold a conference call to discuss its first quarter 2026 financial results on Wednesday, April 29, 2026, at 2:30 p.m. PT/5:30 p.m. ET. The event will be webcast live, and the audio and associated slides will be available for at least three months thereafter at www.amazon.com/ir. View source version on businesswire.com: https://www.businesswire.com/news/home/20260415758081/en/ Amazon.com Public Relations [email protected] amazon.com/ir

    4/15/26 4:01:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amazon to Acquire Globalstar and Expand Amazon Leo Satellite Network

    Globalstar satellites, radio frequency spectrum, and operational expertise will enable Amazon Leo to add Direct-to-Device (D2D) services to future generations of its low Earth orbit satellite network New Amazon Leo D2D system will help mobile network operators extend voice, text, and data services to customers beyond the reach of terrestrial cellular networks Amazon and Apple enter agreement for Amazon Leo to power satellite services for supported iPhone and Apple Watch models, allowing users to text emergency services, message friends and family, request roadside assistance, and more Today Amazon.com, Inc. (NASDAQ:AMZN) and Globalstar, Inc. (NASDAQ:GSAT) announced that they have ente

    4/14/26 8:00:00 AM ET
    $AMZN
    $GSAT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Telecommunications Equipment

    Palisade Bio Reports Positive Topline Data from Phase 1b Clinical Study of PALI-2108 in Fibrostenotic Crohn's Disease

    PALI-2108 demonstrated favorable safety and tolerability with no serious adverse events after two weeks of treatment in a difficult-to-treat populationPhase 1b data demonstrate endoscopic improvement, with a 47.5% reduction in SES-CD score and 40% of patients achieving endoscopic response and 40% of patients achieving endoscopic remissionPharmacokinetic and pharmacodynamic data from ileal tissue and plasma support once-daily oral dosing for Crohn's disease showing IC90 coverage, with correlation to accepted inflammatory biomarkers Data support expansion into broader luminal CD, an indication that has regulatory clarity, more than doubles the total addressable patient population, and has no a

    3/30/26 4:01:00 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMZN
    $ARVL
    $IRBT
    $ONMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Palisade Bio Inc.

    SC 13G - PALISADE BIO, INC. (0001357459) (Subject)

    11/14/24 3:35:13 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by iRobot Corporation

    SC 13G - IROBOT CORP (0001159167) (Subject)

    11/14/24 12:01:27 PM ET
    $IRBT
    Consumer Electronics/Appliances
    Consumer Discretionary

    SEC Form SC 13G filed by OneMedNet Corp

    SC 13G - OneMedNet Corp (0001849380) (Subject)

    11/12/24 3:35:37 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care